Match Document Document Title
US20140302129 HUMAN LUBRICATION GEL  
Human lubricating gels, methods and kits for delivering a therapeutic agent to a target tissue site beneath the skin of a patient utilizing human lubricating gel are provided, the human...
US20070275052 Pharmaceutical compositions containing sterol inhibitors  
Pharmaceutical compositions containing ezetimibe or its pharmaceutically acceptable salt that is substantially free of microcrystalline cellulose or crystalline cellulose are disclosed. Also...
US20070003611 Novel method of granulating calcium carbonate and products provided therefrom  
A new and useful method of granulating calcium carbonate is provided. Such a method entails the inclusion of very low amounts of an aqueous solution citric acid to a calcium carbonate material,...
US20110159083 Nanoparticles for protein drug delivery  
The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge. The bioactive agent is hydrophobic or...
US20080014248 Photosensitizer containing indole-3-alkylcarboxylic acid, and kit for photodynamic therapy containing the same  
The present invention relates to a photosensitizer containing indole-3-alkylcarboxyl acid (ICA), and kit for photodynamic therapy containing the same. More specifically, the present invention is...
US20100221322 Abuse-Resistant Pharmaceutical Dosage Form  
A solid pharmaceutical dosage form that is safeguarded against abuse containing at least one active substance that could be subject to abuse and at least one antagonist for the active substance,...
US20100196464 ORLISTAT PHARMACEUTICAL FORMULATIONS  
Solid pharmaceutical formulations are prepared using compositions comprising orlistat and having average particle sizes less than about 250 μm.
US20070077293 Film-forming composition suitable for hard capsules and method for preparing the same  
The present invention relates to a film-forming composition suitable for hard capsules, and a preparation method thereof. More particularly, the invention relates to a film-forming composition for...
US20150110863 SULFORAPHANE-DERIVED COMPOUNDS, PRODUCTION METHOD THEREOF AND THE MEDICAL, FOOD AND COSMETIC USE OF SAME  
The present invention relates to a new series of compounds having general formula (I) and the optical isomer or enantiomer forms thereof, which belong to the family of sulforaphane derivatives....
US20090004262 Nanoparticulate formulations and methods for the making and use therof  
The present invention is directed to size-stabilized drug nanoparticulate compositions and methods of preparation thereof.
US20100255082 Functionally Coated Breakable Tablets  
Tablet and capsule formulations with a similar in vitro drug release profile for whole tablet and when broken and/or a bioequivalent drug release profile when taken whole or when broken are...
US20070154540 Composition for treatment of osteoarthritis containing apigenin as chondroregenerative agent  
Disclosed is a novel use of apigenin as a chondroregenerative agent, which has the effects of reducing elevated of cartilage destruction markers including total synovial fluid volume and...
US20120315326 MULTIPARTICULATE L-CARNITINE COMPOSITIONS AND RELATED METHODS  
Enteric coated multiparticulate compositions that use a L-carnitine compound an active ingredient are disclosed. The multiparticulates have spheroidal core comprising a L-carnitine,...
US20070031347 Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate  
The invention relates to powdered preparations for inhalation containing a tiotropium salt and salmeterol xinafoate, processes for preparing them and their use in the preparation of a...
US20150050333 PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT  
Provided is a pharmaceutical composition having a single dosage form including a compartment including olmesartan medoxomil; and a compartment including rosuvastatin or its salt, wherein said...
US20150190398 POLYMERIC NANOPARTICLES IN A THERMOSENSITIVE GEL FOR COITAL-INDEPENDENT VAGINAL PROPHYLAXIS OF HIV  
An antiretroviral composition that gels upon heating and can be administered prophylactically prior to exposure to a retrovirus following sexual intercourse, and methods of using the same.
US20060141023 Pharmaceutical compositions containing abiguanide-glitazone combination  
The present invention relates to an orally administered pharmaceutical composition that is a combination of two or more antidiabetic agents in which one of the antidiabetic agents is present in an...
US20060222700 Tablet and capsule form of liquid active ingredient  
A tablet includes a liquid active ingredient, such as benzonatate, and a powdered material, such as fumed silica. The powdered material has adsorbed a high proportion by weight of the liquid...
US20140154310 PHARMACEUTICAL COMPOSITIONS COMPRISING FATTY ACIDS  
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
US20050123601 Capsule for rapid solubilization and release of the content  
The present invention relates to a capsule comprising a core and at least one envelope comprising at least one film-forming polymer, characterized in that it exhibits a total solubilization time...
US20150258130 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF  
The present disclosure provides meroduplex (nicked or gapped) ribonucleic acid molecules (mdRNA) that decreases or silences target gene expression. An mdRNA of this disclosure comprises at least...
US20070098779 Films and capsules made from modified carboxymethylcellulose materials  
Films and/or capsules for the delivery of and/or coating of active ingredients are provided. Such edible films and/or capsules comprise particular modified carboxymethylcellulose (CMC) materials...
US20140134240 pH INDUCED SILK GELS AND USES THEREOF  
This invention provides for compositions, methods and devices for rapidly converting silk fibroin solution into a silk fibroin gel using direct application of voltage, in a process called...
US20090074854 COMBINED-STEP PROCESS FOR PHARMACEUTICAL COMPOSITIONS  
The invention relates to a process for the solid oral pharmaceutical formulation of a pharmaceutically active ingredient such as levetiracetam, comprising a wet granulation of the pharmaceutically...
US20070184099 Films for use as dosage forms  
Non gelatin film materials e.g. films of modified cellulose materials find use as dosage forms. Substances are incorporated into the film matrix and films thus prepared may be administered really,...
US20060210592 Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis  
An oral preparation consisting of a non-systemic antibiotic and a proton pump blocker used for prevention of aspiration pneumonia and sepsis; and a method of prevention of aspiration pneumonia...
US20060002997 Nitrofurantoin controlled release dosage form  
The present invention generally relates to controlled release dosage forms which provide immediate release and sustained release of nitrofurantoin, and processes for their preparation. The...
US20100278910 RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME  
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the...
US20070098781 Modified release compositions for DPP-IV inhibitors  
The present invention refers to pharmaceutical composition comprising a DPP-IV inhibitor.
US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions  
Spontaneously dispersible N-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of...
US20090010975 Non-transparent composition for film  
The present invention provides a non-transparent film composition that has light-shielding properties and can thereby maintain the stability and quality of products, such as formulations, for a...
US20070231273 Method for Decreasing Blood Glucose Levels  
A method for decreasing blood glucose levels is disclosed. Iptakalim hydrochloride (a SUR1 subunit-dependent KATP channel blocker and a SUR2 subunit-selective KATP channel opener) is used to block...
US20100260833 ABUSE-PROOFED DOSAGE FORM  
The invention relates to a solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active substances that have...
US20060002998 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations  
The present invention relates to orally administered pharmaceutical compositions that include a combination of antidiabetic agents wherein one agent is present in an extended release form and the...
US20130028968 COMPOSITIONS AND METHODS TO RELIEVE CHRONIC DISEASES SYMPTOMS  
Compounds having unique properties are prepared from the herbal compositions described herein and comprise extracts derived from plants and fungi of the genera Panax, Ganoderma, and Saussurea. The...
US20060204567 Potato proteinase inhibitor II exhibits activity in elevating fasting plasma cholecystokinin concentrations  
A method of increasing fasting levels of cholecystokinin in a subject by the administration of potato proteinase inhibitor II is described. A method for extending satiety in a subject with...
US20140294946 PHARMACEUTICAL COMPOUNDS  
Fused pyrimidines of formula (I): wherein R1-R3, A and n have any of the values described in the specification; and pharmaceutically acceptable salts thereof; have activity as inhibitors of PI3K...
US20140234406 NOVEL NANOPARTICULATE SUSPENSION FOR INCORPORATING FAT-SOLUBLE VITAMINS IN THE TREATMENT OF HAIR THINNING and HAIR LOSS  
The present invention provides novel compositions comprising a nutritional supplement containing vitamin D-3 (cholecalciferol) and other supporting nutrients (i.e., fat-soluble vitamins A and E)...
US20100209480 GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS  
The present invention relates to a pharmaceutical oral fixed dose combination comprising a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof,b) a...
US20130273152 ANTI-ABUSE PHARMACEUTICAL COMPOSITIONS  
This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated...
US20050202080 In process conversion method for preparing tannate tablet, capsule or other solid dosage forms  
The present invention relates generally to the field of tannate chemistry and more specifically to methods for processing tannate tablets, capsules, or other solid dosage forms. The present...
US20070264324 Use of Vegetable Anthraquinone Derivatives and Vegetable Polysaccharides For Treating Human Immunodeficiency Virus (HIV)  
The use of vegetable anthraquinone derivatives and vegetable polysaccharides for treating human immunodeficiency virus(HIV); the anthraquinone derivatives and polysaccharides were obtained by CO2...
US20080213356 Pharmaceutical Composition Containing Hmg-Coa Reductase Inhibitor And Method For The Preparation Thereof  
The present invention relates to the formulation of solid dosage forms comprising a therapeutically effective amount of an HMG-CoA reductase inhibitor, and especially Fluvastatin or Atorvastatin...
US20070202159 PHARMACEUTICAL COMPOSITION COMPRISING STABILIZED STATIN PARTICLES  
The present invention relates to stabilized statin particles and process for preparation thereof.
US20110038806 MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A STEROID  
A pharmaceutical composition comprising a compound of formula 1 wherein X− is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable...
US20070048364 Free flowing granules containing carbomer  
Methods for making granules containing a carbomer whereby the carbomer is mixed with a hot-melt binder that does not lower the glass transition temperature of the carbomer more than 20° C., the...
US20100291197 HOT MELT-FILLED SOFT CAPSULES  
The present invention relates to a soft capsule, comprising a capsule case and a filling material with at least one pharmacologically or physiologically active substance, characterized in that the...
US20100055171 Pharmaceutical Formulation Comprising Donepezil  
The present invention relates to a pharmaceutical composition comprising 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl ]methyl]-1H-inden-1-one, herein after referred to as...
US20070065364 Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same  
The present invention relates to co-extruded pharmaceutical compositions and dosage forms comprising an adverse agent, such as an opioid antagonist, which can be sequestered. The pharmaceutical...
US20060159741 Pharmaceutical compositions comprising amoxicillin and clavulanic acid  
The present invention relates to the formed particles comprising amoxicillin and clavulanic acid, the particles being obtained wet granulation. The invention also relates to the procedure for the...